Calcium in PDB 8fd7: Structure of the Human L-Type Voltage-Gated Calcium Channel CAV1.2 Complexed with Gabapentin

Other elements in 8fd7:

The structure of Structure of the Human L-Type Voltage-Gated Calcium Channel CAV1.2 Complexed with Gabapentin also contains other interesting chemical elements:

Sodium (Na) 1 atom

Calcium Binding Sites:

The binding sites of Calcium atom in the Structure of the Human L-Type Voltage-Gated Calcium Channel CAV1.2 Complexed with Gabapentin (pdb code 8fd7). This binding sites where shown within 5.0 Angstroms radius around Calcium atom.
In total 3 binding sites of Calcium where determined in the Structure of the Human L-Type Voltage-Gated Calcium Channel CAV1.2 Complexed with Gabapentin, PDB code: 8fd7:
Jump to Calcium binding site number: 1; 2; 3;

Calcium binding site 1 out of 3 in 8fd7

Go back to Calcium Binding Sites List in 8fd7
Calcium binding site 1 out of 3 in the Structure of the Human L-Type Voltage-Gated Calcium Channel CAV1.2 Complexed with Gabapentin


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 1 of Structure of the Human L-Type Voltage-Gated Calcium Channel CAV1.2 Complexed with Gabapentin within 5.0Å range:
probe atom residue distance (Å) B Occ
D:Ca1210

b:30.0
occ:1.00
OG D:SER265 2.4 64.8 1.0
OG1 D:THR333 2.4 64.7 1.0
OG D:SER263 2.9 57.4 1.0
OD2 K:ASP151 3.6 95.4 1.0
CB D:THR333 3.6 59.6 1.0
CB D:SER265 3.7 63.8 1.0
CB D:SER263 3.9 55.8 1.0
CG2 D:THR333 3.9 56.8 1.0
OD2 D:ASP261 4.0 47.9 1.0
OD1 D:ASP365 4.4 64.1 1.0
OD2 D:ASP365 4.6 63.8 1.0
OD1 D:ASP261 4.6 48.8 1.0
O D:GLY366 4.7 57.7 1.0
CA D:SER265 4.7 62.0 1.0
CG K:ASP151 4.7 100.0 1.0
CG D:ASP261 4.7 47.5 1.0
N D:SER265 4.7 58.9 1.0
CA D:THR333 4.8 58.2 1.0
CG D:ASP365 5.0 64.0 1.0
N D:THR333 5.0 52.6 1.0

Calcium binding site 2 out of 3 in 8fd7

Go back to Calcium Binding Sites List in 8fd7
Calcium binding site 2 out of 3 in the Structure of the Human L-Type Voltage-Gated Calcium Channel CAV1.2 Complexed with Gabapentin


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 2 of Structure of the Human L-Type Voltage-Gated Calcium Channel CAV1.2 Complexed with Gabapentin within 5.0Å range:
probe atom residue distance (Å) B Occ
K:Ca1706

b:30.0
occ:1.00
O28 K:WO91701 3.6 0.0 1.0
C23 K:WO91701 4.0 0.0 1.0
O K:MET362 4.1 69.6 1.0
O26 K:WO91701 4.1 0.0 1.0
O K:GLY705 4.1 59.3 1.0
C21 K:WO91701 4.3 0.0 1.0
C29 K:WO91701 4.3 0.0 1.0
OE1 K:GLU363 4.3 83.0 1.0
P25 K:WO91701 4.3 0.0 1.0
O K:THR361 4.5 54.0 1.0
O24 K:WO91701 4.7 0.0 1.0
C K:GLY705 4.7 56.2 1.0
C22 K:WO91701 4.7 0.0 1.0
CA K:CA1707 4.9 30.0 1.0
C K:MET362 5.0 64.8 1.0
O32 K:WO91701 5.0 0.0 1.0

Calcium binding site 3 out of 3 in 8fd7

Go back to Calcium Binding Sites List in 8fd7
Calcium binding site 3 out of 3 in the Structure of the Human L-Type Voltage-Gated Calcium Channel CAV1.2 Complexed with Gabapentin


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 3 of Structure of the Human L-Type Voltage-Gated Calcium Channel CAV1.2 Complexed with Gabapentin within 5.0Å range:
probe atom residue distance (Å) B Occ
K:Ca1707

b:30.0
occ:1.00
OE1 K:GLU363 2.5 83.0 1.0
OE2 K:GLU1115 3.0 69.8 1.0
CD K:GLU363 3.2 86.7 1.0
OE2 K:GLU363 3.2 86.8 1.0
OE1 K:GLU706 3.2 69.0 1.0
OE1 K:GLU1115 3.8 74.1 1.0
CD K:GLU1115 3.8 72.4 1.0
O K:GLY1415 3.8 87.7 1.0
CD K:GLU706 4.1 65.0 1.0
OE2 K:GLU706 4.4 66.4 1.0
OE1 K:GLU1416 4.5 92.7 1.0
N K:ASP707 4.5 50.7 1.0
CG K:GLU363 4.6 79.4 1.0
OE2 K:GLU1416 4.6 92.6 1.0
CA K:GLU706 4.8 58.8 1.0
CD K:GLU1416 4.8 91.8 1.0
O K:PHE1114 4.8 63.5 1.0
O K:MET362 4.8 69.6 1.0
CA K:GLU363 4.9 77.0 1.0
O K:GLY705 4.9 59.3 1.0
CA K:CA1706 4.9 30.0 1.0

Reference:

Z.Chen, A.Mondal, D.L.Minor. Structural Basis For CAVALPHA2DELTA:Gabapentin Binding To Be Published.
Page generated: Tue Apr 11 12:44:54 2023

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy